Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.41 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 3/20 | 0.35 |
| ▸ | CHEK2 | O96017 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.33 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.33 |
| ▸ | ITGAL | P20701 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL880222 | 0.76 | BAZ2B (0.47) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL19214670 | 0.73 | BAZ2B (0.44) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL433905 | 0.73 | BAZ2B (0.49) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL25694428 | 0.73 | BAZ2B (0.44) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL3715486 | 0.73 | BAZ2B (0.44) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL24762447 | 0.73 | BAZ2B (0.44) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL15668445 | 0.73 | BAZ2B (0.44) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL12414587 | 0.73 | BAZ2B (0.44) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL982629 | 0.73 | BAZ2B (0.49) | BAZ2BHTTHPGDNCOA1NCOA3 | |
| SCHEMBL5015667 | 0.72 | HTT (0.41) | BAZ2BHTTHPGDNCOA1NCOA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070071987-A1 | Base-inhibited oxidative polymerization of thiophenes and anilines with iron (III) salts | NANON A/S (DK) | 2007-03-29 | — | — | US | claimed |
| CN-117596920-A | Light-emitting element | 三星显示有限公司 | 2024-02-23 | — | — | CN | disclosed |
| EP-3562810-B1 | BENZHYDROXAMIC ACID DERIVATIVES AS SELECTIVE HDAC6 INHIBITORS | ITALFARMACO SPA (IT) | 2023-05-03 | — | — | EP | disclosed |
| US-11077098-B2 | Opioid receptor ligands and methods of using and making same | TREVENA, INC. (US) | 2021-08-03 | — | — | US | disclosed |
| WO-2020078815-A1 | INDACENO DERIVATIVES AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2020-04-23 | — | — | WO | disclosed |
| WO-2017089952-A1 | DEGRADABLE CONJUGATED POLYMERS | The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel (US) | 2017-06-01 | — | — | WO | disclosed |
| WO-2012121417-A1 | CONDUCTING POLYMER / REDOX POLYMER BLENDS VIA IN-SITU OXIDATIVE POLYMERIZATION - PREPARATION METHODS AND APPLICATION AS AN ELECTRO-ACTIVE POLYMERIC MATERIALS | WASEDA UNIVERSITY (JP) | 2012-09-13 | — | — | WO | disclosed |
| US-20070071987-A1 | Base-inhibited oxidative polymerization of thiophenes and anilines with iron (III) salts | NANON A/S (DK) | 2007-03-29 | — | — | US | disclosed |
| EP-1765908-A1 | BASE-INHIBITED OXIDATIVE POLYMERIZATION OF THIOPHENES AND ANILINES WITH IRON (III) SALTS | Nanon A/S (DK) | 2007-03-28 | — | — | EP | disclosed |
| WO-2005103109-A1 | BASE-INHIBITED OXIDATIVE POLYMERIZATION OF THIOPHENES AND ANILINES WITH IRON (III) SALTS | WINTHER-JENSEN BJOERN (AU) | 2005-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11077098-B2 | Opioid receptor ligands and methods of using and making same | OPRL1, OPRK1, OPRM1 | BAZ2B 4599/4885HTT 1382/4885HPGD 776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.